What to expect: Cross-class switch from pure GLP-1 (dulaglutide) to dual GIP/GLP-1 (tirzepatide). Same T2D indication. Restart titration from Mounjaro 2.5 mg. Allow GI adjustment.
Drug-clearance reference: Trulicity takes roughly 7 days to clear based on its half-life. Your prescriber decides the actual overlap or gap for your switch — this is background, not a schedule to follow on your own.
Why patients switch from Trulicity to Mounjaro
- Greater A1C reduction — SURPASS-2 head-to-head: tirzepatide reduced A1C ~2.3% vs semaglutide ~1.9%
- Greater weight loss — Mounjaro produces ~15-20 lb vs Trulicity ~3-7 lb at max doses
- Plateau on max Trulicity dose (4.5 mg) without reaching A1C goal
- Insurance shifted preferred T2D formulary to Mounjaro
- Both are Lilly products — common provider preference path
Side effects during the Trulicity → Mounjaro transition
- Nausea (tirzepatide > dulaglutide for GI burden)
- Constipation
- Decreased appetite (more pronounced on Mounjaro)
- A1C may dip more rapidly during transition
Discuss with your prescriber before switching
This guide is editorial — not medical advice. Switching GLP-1 medications must be supervised. Bring this checklist to your appointment:
- Required — A1C target review
- If on insulin/sulfonylurea (hypoglycemia risk)
- If history of medullary thyroid cancer or MEN-2 (contraindication for both)
Dose conversion: Trulicity → Mounjaro
Use this table as a starting reference only. Final dose depends on your tolerance, weight-loss trajectory, and prescriber guidance. Never self-titrate based on a chart.
| Trulicity dose | Mounjaro dose | Note |
|---|---|---|
| Any | Restart titration from lowest dose | Different mechanism (dulaglutide → tirzepatide). No direct conversion. |
Transition timeline
Plan on 2-week prep + 12-week evaluation window. Most weight-loss outcomes can be re-assessed at the 12-week mark on the new medication.
Week −2: Decision + prescriber alignment
Confirm with your prescriber: dose-equivalent target, expected side-effect profile differences (dulaglutide → tirzepatide), insurance implications.
Week −1: Last Trulicity dose
Continue your current Trulicity schedule. Trulicity has a half-life of about 5 days, so effects persist for a couple of weeks after the last dose.
Week 0: First Mounjaro dose
Restart titration from lowest Mounjaro dose. Overlap effect possible in the first 7-10 days as Trulicity clears.
Weeks 1-4: Stabilization
Side-effect profile shifts. GI symptoms (nausea, constipation) may be more pronounced. Track weight + appetite.
Weeks 4-12: Re-evaluation
Compare outcomes to your Trulicity baseline. If weight-loss trajectory hasn't improved by week 12, discuss whether the switch was right.
Beyond 12 weeks
If outcomes good, continue. If switch underperformed Trulicity, discuss reverting or trying a third option (often semaglutide-based).
FAQ — Trulicity → Mounjaro
Can I take Trulicity and Mounjaro together?
No. Combining GLP-1 medications isn't done outside clinical trials. Stop Trulicity before starting Mounjaro; the long half-lives mean overlap occurs naturally.
Will I lose ground when switching from Trulicity to Mounjaro?
Possibly temporarily. Most patients maintain weight during a clean switch when restart dose is appropriate. The bigger risk is regression if the switch fails to match Trulicity efficacy. Plan and 12-week evaluation window.
Does insurance cover Mounjaro if it covered Trulicity?
Different molecule means different formulary placement. Run a fresh prior authorization for Mounjaro — coverage of Trulicity doesn't transfer automatically.
How long does Trulicity stay in my system after the last dose?
Liraglutide has a 13-hour half-life — effects clear in 2-3 days. Daily dosing means transitions are quicker.
Cost comparison
Cash-pay pricing differs significantly between Trulicity and Mounjaro. Run the true-cost calculator with your insurance details for an apples-to-apples comparison including coupons and patient assistance programs. Open true cost calculator →
Provider match
Find a provider that offers Mounjaro
Continuity of care matters during a switch. We compared US telehealth providers ranked by Mounjaro availability, price, and prescriber accessibility.
See top Mounjaro providers →Affiliate disclosure: we earn commission on provider sign-ups. Learn more
Next steps
Before switching, read our full Trulicity review and Mounjaro review.
Sources
- FDA Trulicity prescribing information
- FDA Mounjaro prescribing information
- SURPASS-2 trial (NEJM 2021)
Not medical advice. Switching GLP-1 medications must be done with prescriber supervision. This guide is editorial summary based on published prescribing information and clinical guidance. Full medical disclaimer.